CJC-1295/Ipamorelin Blend 10MG

CJC-1295 Ipamorelin blend from Maple Research Labs combines two complementary growth hormone secretagogue peptides in a single 10mg research vial with verified 99%+ purity.

n

This blend contains 5mg of CJC-1295 (No DAC), also known as Mod GRF 1-29, and 5mg of Ipamorelin, a selective growth hormone releasing peptide. Researchers in the USA studying the synergistic mechanisms of GHRH analogs and GHRPs can access both compounds in a pre-blended, research-ready format from Maple Research Labs.

n

Research Background

n

CJC-1295 (No DAC) is a modified growth hormone releasing hormone analog consisting of 29 amino acids. Research by Ionescu and Bhatt (2006) examined the pharmacokinetic properties of modified GRF analogs. Ipamorelin is a pentapeptide growth hormone secretagogue that acts through the ghrelin receptor (GHS-R1a). Research by Raun et al. (1998) characterized Ipamorelin as a potent and selective growth hormone secretagogue in preclinical models.

n

Product Specifications

n

n
• CAS Number: Blend (CJC-1295: 863288-34-0 / Ipamorelin: 170851-70-4)

n

• Purity: >99%+ (HPLC verified, each component)

n

• Form: Lyophilized powder

n

• Quantity: 10mg per vial (5mg CJC-1295 No DAC + 5mg Ipamorelin)

n

n

Quality Assurance at Maple Research Labs

n

Every batch of CJC-1295 Ipamorelin blend from Maple Research Labs undergoes rigorous HPLC purity testing. We provide third-party COA testing documentation so researchers can independently verify the identity and purity of the compounds.

n

Certificate of Analysis

n

View Third-Party COA (Testides Analytical) – 99.55% Purity – Batch DBAV-CJCI-10-051226-02

n

For research purposes only. Not for human consumption. Not for diagnostic or therapeutic use.